University of California, Davis: Lung Neoplasms trials
The registry lists 22 Lung Neoplasms studies with University of California, Davis as lead sponsor. 3 are open to participants now and 6 have results posted.
Early Phase 1 2Phase 1 12Phase 2 7No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung CancerRecruitingNCT05452005Phase 1
- Patient-Derived Xenografts to Reduce Cancer Health DisparitiesRecruitingNCT04410302
- Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung CancerRecruitingNCT00899405
- Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal CancerCompletedNCT01676714Phase 2Results posted
- Abraxane and Alimta in Advanced Solid TumorsTerminatedNCT00470548Phase 1/2Results posted
- Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung CancerCompletedNCT00408499Phase 1/2Results posted
- Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00390429Phase 1/2Results posted
- Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00389805Phase 1/2Results posted
- Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung CancerCompletedNCT00387660Phase 2Results posted
- Enhancing Lung Cancer Screening Through Human-Centered InterventionActive, not recruitingNCT06351085Not applicable
- The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint InhibitorsSuspendedNCT05967533Phase 1
- Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER CancerCompletedNCT04540081Not applicable
- Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and MelanomaActive, not recruitingNCT04478318Not applicable
- [18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed TherapyWithdrawnNCT04186988Early Phase 1
- UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.CompletedNCT03224871Early Phase 1
- Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung CancerCompletedNCT02194049Phase 1
- INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung CancerCompletedNCT01911507Phase 1
- CTP Imaging of Lung CancerCompletedNCT01823094
- Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid TumorsCompletedNCT01336842Phase 1
- Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid TumorsTerminatedNCT00807755Phase 1
- Bortezomib and Topotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00388089Phase 1
- Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00387322Phase 1/2